Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
3.88
0.26 (7.18%)
At close: Jun 06, 2025, 3:59 PM
3.91
0.77%
After-hours: Jun 06, 2025, 07:32 PM EDT
Cardiff Oncology Revenue Breakdown
| Period Ending | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|
| Royalty Revenue | 365.99K | 243.14K |
| Royalty Revenue Growth | +50.53% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.01M | 3.01M | 3.13M | 3.11M | 3.03M | 2.62M | 2.94M | 4.3M | 3.08M | 3.08M | 3.08M | 3.09M | 3.94M | 3.83M | 2.93M | 2.84M | 2.23M | 3.42M | 1.64M | 1.67M | 1.49M | 1.52M | 2.88M | 1.53M | 1.48M | 1.69M | 1.67M | 2.15M | 2.5M | 1.87M | 4.08M | 4.67M | 3.6M | 4.69M | 5.65M | 5.6M | 7.06M | 4.1M | 3.75M | 3.92M | 2.6M |
| Selling, General, and Administrative Revenue Growth | +33.31% | -3.68% | +0.51% | +2.71% | +15.48% | -10.79% | -31.59% | +39.34% | +0.16% | +0.03% | -0.29% | -21.68% | +2.74% | +30.89% | +3.24% | +26.98% | -34.59% | +107.82% | -1.50% | +12.33% | -2.04% | -47.34% | +88.53% | +3.59% | -12.46% | +1.19% | -22.58% | -14.14% | +33.67% | -54.06% | -12.72% | +29.67% | -23.11% | -17.05% | +0.96% | -20.73% | +72.28% | +9.40% | -4.37% | +50.66% | n/a |
| Research and Development Revenue | 10.48M | 9.71M | 9.64M | 9.49M | 8.01M | 7.76M | 8.02M | 8.02M | 9.05M | 6.44M | 6.01M | 7.45M | 7.21M | 5.82M | 4.15M | 4.12M | 3.28M | 3.2M | 2.85M | 2.48M | 2.71M | 2.87M | 2.82M | 2.83M | 2.65M | 2.5M | 1.83M | 1.95M | 1.88M | 1.21M | 1.41M | 981.72K | 4.28M | 3.79M | 3.94M | 4.08M | 3.21M | 3.17M | 2.55M | 2.68M | 2.2M |
| Research and Development Revenue Growth | +7.88% | +0.75% | +1.55% | +18.54% | +3.16% | -3.23% | +0.02% | -11.40% | +40.52% | +7.21% | -19.32% | +3.33% | +23.76% | +40.20% | +0.85% | +25.62% | +2.50% | +12.06% | +15.31% | -8.50% | -5.56% | +1.64% | -0.39% | +6.83% | +6.09% | +36.42% | -6.26% | +3.66% | +56.08% | -14.68% | +44.11% | -77.06% | +13.07% | -3.87% | -3.41% | +27.07% | +1.33% | +24.33% | -5.12% | +22.13% | n/a |